Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Microtox CTM installed ahead of Winter Olympics

6 Jan 2022 07:00

RNS Number : 5684X
Deepverge PLC
06 January 2022
 

6 January 2022

 

DeepVerge PLC

("DeepVerge" or "Company")

 

Microtox water testing equipment installed ahead of Beijing 2022 Winter Olympics

 

DeepVerge (LSE:DVRG.L), announces that its environmental division, Modern Water, has completed installation of Microtox® Continuous Toxicity Monitor ("CTM") permanent units and Microtox® FX portable laboratory units in Beijing, China, ahead of the athletes arriving at the 2022 Winter Olympics Village.

 

Microtox® CTM is a site-based, broad range Continuous Toxicity Monitor that continuously measures the chemical toxicity of a water source, giving instant indication of water health. It is a fully automatic instrument that offers a 4-week, autonomous operating cycle and requires a low level of skill for both operation and maintenance.

 

Microtox® FX has a combined detection capability that provides a very sensitive and rapid test to detect two of the most probable classes of agents, pathogens and toxic chemicals that may accidentally or intentionally contaminate drinking water or wastewater. Microtox® FX's acute toxicity and ATP (adenosine triphosphate) detection capabilities make it the ideal instrument for rapidly and accurately assessing if the quality of drinking water, from the source to the tap, has been affected by an incident.

 

Gerard Brandon, CEO of DeepVerge plc, commented:

 

"Once again, water suppliers to the Olympic Games have placed their trust, and the safety of athletes and officials, in the hands of Modern Water. The company's Microtox® toxicity testing has been used at every Olympics competition since Los Angeles 1984, apart from last year's Tokyo Olympics because of travel restrictions. With the Covid-19 pandemic still affecting much of the world, the importance of identifying pathogens in water can't be overstated, which is why Modern Water is working with governments to help track the virus and even predict where future outbreaks could occur."

 

DeepVerge plc

Gerry Brandon

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments and the data they generate, for the analysis and identification of bacteria, virus and toxins. DeepVerge is utilising artificial intelligent data analytics to prove scientifically the impact of skincare product claims on the skin microbiome for clients including most of the top 20 global cosmetic companies and to detect remotely, and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABAMRTMTIMBRT

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.